EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk

Armelle deLaforcade, Lenore Bacek iD, Marie-Claude Blais iD, Corrin Boyd iD, Benjamin M Brainard iD, Daniel L Chan iD, Stefano Cortellini, Robert Goggs iD, Guillaume L Hoareau iD, Amy Koenigshof, Ron Li iD, Alex Lynch iD und 3 weitere

Journal of Veterinary Emergency and Critical Care · 2022-05 · 32 (3) · 289-314

DOI: 10.1111/vec.13204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Emergency and Critical Care, online erschienen am 02.05.2022. Verfasst von Armelle deLaforcade und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA. Hauptthemen laut MEDLINE: Adrenocortical Hyperfunction, Anemia, Hemolytic, Autoimmune, Cat Diseases, Dirofilariasis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 369 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To expand the number of conditions and interventions explored for their associations with thrombosis in the veterinary literature and to provide the basis for prescribing recommendations.

Design

A population exposure comparison outcome format was used to represent patient, exposure, comparison, and outcome. Population Exposure Comparison Outcome questions were distributed to worksheet authors who performed comprehensive searches, summarized the evidence, and created guideline recommendations that were reviewed by domain chairs. The revised guidelines then underwent the Delphi survey process to reach consensus on the final guidelines. Diseases evaluated in this iteration included heartworm disease (dogs and cats), immune‐mediated hemolytic anemia (cats), protein‐losing nephropathy (cats), protein‐losing enteropathy (dogs and cats), sepsis (cats), hyperadrenocorticism (cats), liver disease (dogs), congenital portosystemic shunts (dogs and cats) and the following interventions: IV catheters (dogs and cats), arterial catheters (dogs and cats), vascular access ports (dogs and cats), extracorporeal circuits (dogs and cats) and transvenous pacemakers (dogs and cats).

Results

Of the diseases evaluated in this iteration, a high risk for thrombosis was defined as heartworm disease or protein‐losing enteropathy. Low risk for thrombosis was defined as dogs with liver disease, cats with immune‐mediated hemolytic anemia, protein‐losing nephropathy, sepsis, or hyperadrenocorticism.

Conclusions

Associations with thrombosis are outlined for various conditions and interventions and provide the basis for management recommendations. Numerous knowledge gaps were identified that represent opportunities for future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenocortical HyperfunctionAnemia, Hemolytic, AutoimmuneCat DiseasesDirofilariasisDog DiseasesProtein-Losing EnteropathiesSepsisThrombosisAnimalsCatsCritical CareDogsFibrinolytic AgentsRisk Factors

Stichwörter der Autor:innen

arrhythmiasheartworm diseaseprotein-losing enteropathyvascular devices

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.
  • Bluepearl Specialty and Emergency Pet Hospital, Tampa, Florida, USA.
  • Department of Clinical Sciences, University of Montreal, Saint-Hyacinthe, QC, Canada.
  • School of Veterinary Medicine, Murdoch University, Murdoch, Australia.
  • Department of Small Animal Medicine and Surgery, Clinical Sciences, University of Georgia, Athens, Georgia, USA.
  • Department of Clinical Science and Services, The Royal Veterinary College, London, UK.

ORCID-Profile: Lenore Bacek, Marie-Claude Blais, Corrin Boyd, Benjamin M Brainard, Daniel L Chan, Robert Goggs, Guillaume L Hoareau, Ron Li, Alex Lynch, Elizabeth Rozanski

Förderung

  • NCATS NIH HHS

Zitieren

APA

deLaforcade, A., Bacek, L., Blais, M. C., Boyd, C., Brainard, B. M., Chan, D. L., Cortellini, S., Goggs, R., Hoareau, G. L., Koenigshof, A., Li, R., Lynch, A., Ralph, A., Rozanski, E., & Sharp, C. R. (2022). 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk. Journal of Veterinary Emergency and Critical Care, 32(3), 289-314. https://doi.org/10.1111/vec.13204

Vancouver

deLaforcade A, Bacek L, Blais MC, Boyd C, Brainard BM, Chan DL, et al. 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk. Journal of Veterinary Emergency and Critical Care. 2022;32(3):289-314. doi:10.1111/vec.13204

BibTeX
@article{deLaforcade2022,
  author = {deLaforcade, Armelle and Bacek, Lenore and Blais, Marie-Claude and Boyd, Corrin and Brainard, Benjamin M and Chan, Daniel L and Cortellini, Stefano and Goggs, Robert and Hoareau, Guillaume L and Koenigshof, Amy and Li, Ron and Lynch, Alex and Ralph, Alan and Rozanski, Elizabeth and Sharp, Claire R},
  title = {2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2022},
  volume = {32},
  number = {3},
  pages = {289--314},
  doi = {10.1111/vec.13204}
}
Kostenlos starten →